Announcements Trials
Browse Landscape

Phase

Phase NA 5Phase 1 2Phase 3 1Phase 1/2 1

Status

Recruiting 1Active not recruiting 1

Sponsor Class

OTHER 1FED 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Esophageal Neoplasms 1Carcinoma, Hepatocellular 1

Interventions

Specimen Handling 146pembrolizumab 120Magnetic Resonance Spectroscopy 117Cyclophosphamide 114Biopsy 97fludarabine 88Nivolumab 52Carboplatin 51Cisplatin 47Gemcitabine 46venetoclax 41Radiotherapy 41Paclitaxel 40Cetuximab 40fludarabine phosphate 39Ipilimumab 34atezolizumab 33Fluorouracil 33Bevacizumab 33Oxaliplatin 27Leucovorin 27Dexamethasone 27durvalumab 26X-Rays 25Irinotecan 25Radiation 24Cytarabine 24Azacitidine 24Injections 22Temozolomide 21

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 1 × Cryotherapy × 90 days × Clear all
NCT06710223 2026-04-30

Cryoablation and Arterial Infusion of SD-101 in Combination With Durvalumab and Tremelimumab

University of California, San Diego

Phase 1 Recruiting
20 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

NCT04248582 2026-04-15

Cryotherapy for Locally Advanced Esophageal Cancer

Hunter Holmes Mcguire Veteran Affairs Medical Center

Phase 1 Active not recruiting
14 enrolled
Gastrointestinal

Esophageal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡